Ex-Aptuit Employee Gets Jail Time for Manipulation of Trial Data
A man has been given a custodial sentence by a court in Edinburgh, UK after being found guilty of altering preclinical trial data.
Archives for April 17, 2013
ATMI Adds New Single-Use Fill/Finish Tech in Deal with CMO D-Lab
ATMI has started selling a new cGMP-compliant fill finish platform in a continuation of its focus on what it says is the growing single-use tech market.
GSK’s Contract Manufacturing Delays Cause Shortage of Restless Leg Treatment
GlaxoSmithKline’s contract manufacturer has experienced unspecified manufacturing issues that are expected to set back supplies of its restless leg treatment Horizant until June.
Metrics Latest Company to Offer Extrusion and Speronization Tech
Following its acquisition by Mayne Pharma, Metrics says it is to offer proprietary pellet form technology for advanced drug release and to increase bioavailability.
Allergan CMO Issues Prompt US FDA to Reject Migraine Drug Again
US regulators have rejected Allergan's candidate migraine drug Levadex for a second time, this time citing concerns about the CMO - Exemplar Pharma - the Californian drugmaker acquired earlier in the week for $20m.
World Medical Association Revises Ethical Principles in Clinical Trials Declaration
Draft revisions to the Declaration of Helsinki (DoH) clarify how placebos should be used and add a general principle for adequate compensation to injured trial participants according to the WMA.